Search by Drug Name or NDC
NDC 00904-6921-52 Ranitidine 75 mg/1 Details
Ranitidine 75 mg/1
Ranitidine is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by MAJOR PHARMACEUTICALS. The primary component is RANITIDINE HYDROCHLORIDE.
Product Information
NDC | 00904-6921 |
---|---|
Product ID | 0904-6921_f2d75d05-d8ce-4166-19a9-e9b0265c99a7 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Ranitidine |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Ranitidine |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 75 |
Active Ingredient Units | mg/1 |
Substance Name | RANITIDINE HYDROCHLORIDE |
Labeler Name | MAJOR PHARMACEUTICALS |
Pharmaceutical Class | Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA075294 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00904-6921-52 (00904692152)
NDC Package Code | 0904-6921-52 |
---|---|
Billing NDC | 00904692152 |
Package | 1 BOTTLE in 1 CARTON (0904-6921-52) / 60 TABLET in 1 BOTTLE |
Marketing Start Date | 2019-05-28 |
NDC Exclude Flag | N |
Pricing Information | N/A |